長期投資家のためのIR情報
バリュートレンド

【4586】メドレックス
経皮吸収型製剤技術が強みの創薬ベンチャー
類似企業:
【業界1位】 小野薬品工業

売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2026.12 2026/08/07 Q2予 385 ↓ -24.1% -24.1% -1,206 ↑ +18.1% +18.1% -1,197 ↑ +18.7% +18.7% -1,202 ↑ +20.0% +20.0%
2026.12 2026/05/15 当初予 507 - - - -1,472 - - - -1,472 - - - -1,502 - - -
2025.12 2026/02/13 実 128 ↑ +4.9% +4.9% -941 ↑ +29.5% +29.5% -937 ↑ +29.8% +29.8% -937 ↑ +30.6% +30.6%
2025.12 2025/11/14 Q3予 122 → 0.0% 0.0% -1,335 → 0.0% 0.0% -1,335 → 0.0% 0.0% -1,350 → 0.0% 0.0%
2025.12 2025/08/08 Q2予 122 → 0.0% 0.0% -1,335 → 0.0% 0.0% -1,335 → 0.0% 0.0% -1,350 → 0.0% 0.0%
2025.12 2025/05/09 Q1予 122 → 0.0% 0.0% -1,335 → 0.0% 0.0% -1,335 → 0.0% 0.0% -1,350 → 0.0% 0.0%
2025.12 2025/02/14 当初予 122 - - - -1,335 - - - -1,335 - - - -1,350 - - -
2024.12 2025/02/14 実 257 ↓ -0.8% +28.5% -793 ↑ +13.7% +44.4% -755 ↑ +13.0% +45.4% -806 ↑ +4.7% +41.8%
2024.12 2024/11/08 Q3予 259 → 0.0% +29.5% -919 → 0.0% +35.5% -868 → 0.0% +37.3% -846 → 0.0% +39.0%
2024.12 2024/08/09 Q2予 259 ↑ +6.1% +29.5% -919 ↑ +29.2% +35.5% -868 ↑ +30.9% +37.3% -846 ↑ +32.8% +39.0%
2024.12 2024/07/12 修正予 244 ↓ -44.8% +22.0% -1,298 ↓ -9.7% +8.9% -1,257 ↓ -10.1% +9.2% -1,259 ↓ -10.1% +9.2%
2024.12 2024/05/10 Q1予 442 → 0.0% +121.0% -1,183 → 0.0% +17.0% -1,142 → 0.0% +17.5% -1,144 → 0.0% +17.5%
2024.12 2024/04/24 修正予 442 ↑ +121.0% +121.0% -1,183 ↑ +17.0% +17.0% -1,142 ↑ +17.5% +17.5% -1,144 ↑ +17.5% +17.5%
2024.12 2024/02/09 当初予 200 - - - -1,425 - - - -1,384 - - - -1,386 - - -
2023.12 2024/02/09 実 29 ↑ +7.4% -77.2% -933 ↑ +11.1% -12.4% -930 ↑ +7.3% -18.8% -932 ↑ +7.4% -18.6%
2023.12 2023/11/10 Q3予 27 → 0.0% -78.7% -1,050 → 0.0% -26.5% -1,003 → 0.0% -28.1% -1,006 → 0.0% -28.0%
2023.12 2023/09/29 修正予 27 ↓ -78.7% -78.7% -1,050 ↓ -10.5% -26.5% -1,003 ↓ -11.1% -28.1% -1,006 ↓ -11.0% -28.0%
2023.12 2023/09/15 修正予 127 → 0.0% 0.0% -950 ↓ -14.5% -14.5% -903 ↓ -15.3% -15.3% -906 ↓ -15.3% -15.3%
2023.12 2023/08/10 Q2予 127 → 0.0% 0.0% -830 → 0.0% 0.0% -783 → 0.0% 0.0% -786 → 0.0% 0.0%
2023.12 2023/05/12 Q1予 127 → 0.0% 0.0% -830 → 0.0% 0.0% -783 → 0.0% 0.0% -786 → 0.0% 0.0%
2023.12 2023/02/10 当初予 127 - - - -830 - - - -783 - - - -786 - - -
2022.12 2023/02/10 実 59 → 0.0% -79.6% -1,098 ↑ +7.0% -9.6% -1,112 ↑ +7.3% -10.9% -1,111 ↑ +7.3% -10.4%
2022.12 2022/12/27 修正予 59 ↓ -83.6% -79.6% -1,181 ↓ -34.1% -17.9% -1,200 ↓ -33.3% -19.6% -1,199 ↓ -33.4% -19.2%
2022.12 2022/11/11 Q3予 359 ↑ +24.2% +24.2% -881 ↑ +12.1% +12.1% -900 ↑ +10.3% +10.3% -899 ↑ +10.6% +10.6%
2022.12 2022/08/10 Q2予 289 → 0.0% 0.0% -1,002 → 0.0% 0.0% -1,003 → 0.0% 0.0% -1,006 → 0.0% 0.0%
2022.12 2022/05/13 Q1予 289 → 0.0% 0.0% -1,002 → 0.0% 0.0% -1,003 → 0.0% 0.0% -1,006 → 0.0% 0.0%
2022.12 2022/02/10 当初予 289 - - - -1,002 - - - -1,003 - - - -1,006 - - -
2021.12 2022/02/10 実 8 → 0.0% -97.6% -1,061 ↑ +2.3% -19.8% -1,074 ↑ +2.2% -20.7% -1,059 ↑ +3.8% -18.7%
2021.12 2021/12/27 修正予 8 ↓ -96.5% -97.6% -1,086 ↓ -25.4% -22.6% -1,098 ↓ -25.1% -23.4% -1,101 ↓ -25.0% -23.4%
2021.12 2021/11/19 修正予 228 ↓ -30.5% -30.3% -866 ↓ -13.1% +2.3% -878 ↓ -12.9% +1.3% -881 ↓ -12.8% +1.2%
2021.12 2021/11/12 修正予 328 ↑ +0.3% +0.3% -766 ↑ +31.1% +13.5% -778 ↑ +30.2% +12.6% -781 ↑ +30.1% +12.4%
2021.12 2021/08/10 Q2予 327 → 0.0% 0.0% -1,111 → 0.0% -25.4% -1,115 → 0.0% -25.3% -1,117 → 0.0% -25.2%
2021.12 2021/05/18 修正予 327 → 0.0% 0.0% -1,111 ↓ -25.4% -25.4% -1,115 ↓ -25.3% -25.3% -1,117 ↓ -25.2% -25.2%
2021.12 2021/05/13 Q1予 327 → 0.0% 0.0% -886 → 0.0% 0.0% -890 → 0.0% 0.0% -892 → 0.0% 0.0%
2021.12 2021/02/10 当初予 327 - - - -886 - - - -890 - - - -892 - - -
2020.12 2021/02/10 実 115 → 0.0% -50.9% -1,130 ↑ +0.1% +5.0% -1,152 ↑ +0.1% +3.0% -1,114 ↑ +0.1% +6.5%
2020.12 2020/12/28 修正予 115 ↓ -65.6% -50.9% -1,131 ↓ -3.9% +4.9% -1,153 ↓ -6.0% +2.9% -1,115 ↓ -2.2% +6.4%
2020.12 2020/11/06 Q3予 334 → 0.0% +42.7% -1,089 → 0.0% +8.4% -1,088 → 0.0% +8.4% -1,091 → 0.0% +8.4%
2020.12 2020/08/06 Q2予 334 → 0.0% +42.7% -1,089 → 0.0% +8.4% -1,088 → 0.0% +8.4% -1,091 → 0.0% +8.4%
2020.12 2020/05/13 Q1予 334 → 0.0% +42.7% -1,089 → 0.0% +8.4% -1,088 → 0.0% +8.4% -1,091 → 0.0% +8.4%
2020.12 2020/04/16 修正予 334 ↑ +42.7% +42.7% -1,089 ↑ +8.4% +8.4% -1,088 ↑ +8.4% +8.4% -1,091 ↑ +8.4% +8.4%
2020.12 2020/02/07 当初予 234 - - - -1,189 - - - -1,188 - - - -1,191 - - -
2019.12 2020/02/07 実 169 ↓ -1.7% -83.3% -1,627 ↑ +12.8% -150.3% -1,633 ↑ +12.7% -148.9% -1,616 ↑ +12.9% -151.3%
2019.12 2019/11/08 Q3予 172 → 0.0% -83.0% -1,866 → 0.0% -187.1% -1,871 → 0.0% -185.2% -1,856 → 0.0% -188.6%
2019.12 2019/09/25 修正予 172 ↓ -83.0% -83.0% -1,866 ↓ -96.6% -187.1% -1,871 ↓ -95.9% -185.2% -1,856 ↓ -96.8% -188.6%
2019.12 2019/08/09 Q2予 1,009 → 0.0% 0.0% -949 → 0.0% -46.0% -955 → 0.0% -45.6% -943 → 0.0% -46.7%
2019.12 2019/05/29 修正予 1,009 → 0.0% 0.0% -949 ↓ -46.0% -46.0% -955 ↓ -45.6% -45.6% -943 ↓ -46.7% -46.7%
2019.12 2019/05/10 Q1予 1,009 → 0.0% 0.0% -650 → 0.0% 0.0% -656 → 0.0% 0.0% -643 → 0.0% 0.0%
2019.12 2019/02/08 当初予 1,009 - - - -650 - - - -656 - - - -643 - - -
2018.12 2019/02/08 実 8 → 0.0% -98.9% -1,273 ↑ +9.0% -13.7% -1,285 ↑ +8.9% -15.2% -1,267 ↑ +9.0% -15.2%
2018.12 2018/11/09 Q3予 8 ↓ -98.9% -98.9% -1,399 ↓ -99.6% -24.9% -1,410 ↓ -98.0% -26.5% -1,393 ↓ -99.9% -26.6%
2018.12 2018/08/10 Q2予 698 → 0.0% 0.0% -701 ↑ +3.0% +37.4% -712 ↑ +3.0% +36.1% -697 ↑ +3.1% +36.6%
2018.12 2018/08/07 修正予 698 → 0.0% 0.0% -723 ↑ +35.4% +35.4% -734 ↑ +34.2% +34.2% -719 ↑ +34.6% +34.6%
2018.12 2018/05/11 Q1予 698 → 0.0% 0.0% - - - - -1,115 → 0.0% 0.0% -1,100 → 0.0% 0.0%
2018.12 2018/02/09 当初予 698 - - - -1,120 - - - -1,115 - - - -1,100 - - -
2017.12 2018/02/09 実 198 ↑ +6.5% +661.5% -983 ↑ +22.0% +30.8% -988 ↑ +20.6% +29.6% -884 ↑ +26.7% +35.3%
2017.12 2017/11/10 Q3予 186 → 0.0% +615.4% -1,261 → 0.0% +11.3% -1,244 → 0.0% +11.4% -1,206 → 0.0% +11.7%
2017.12 2017/08/10 Q2予 186 → 0.0% +615.4% -1,261 → 0.0% +11.3% -1,244 → 0.0% +11.4% -1,206 → 0.0% +11.7%
2017.12 2017/05/10 Q1予 186 → 0.0% +615.4% -1,261 → 0.0% +11.3% -1,244 → 0.0% +11.4% -1,206 → 0.0% +11.7%
2017.12 2017/04/06 修正予 186 ↑ +615.4% +615.4% -1,261 ↑ +11.3% +11.3% -1,244 ↑ +11.4% +11.4% -1,206 ↑ +11.7% +11.7%
2017.12 2017/02/10 当初予 26 - - - -1,421 - - - -1,404 - - - -1,366 - - -
2016.12 2017/02/10 実 22 ↓ -24.1% -24.1% -1,342 ↑ +16.5% +36.6% -1,301 ↑ +16.5% +38.1% -1,259 ↑ +18.1% +39.5%
2016.12 2016/08/05 修正予 29 → 0.0% 0.0% - - - - -1,558 ↑ +2.3% +25.9% -1,537 ↑ +2.2% +26.1%
2016.12 2016/05/12 Q1予 29 → 0.0% 0.0% -1,608 ↑ +24.0% +24.0% -1,594 ↑ +24.2% +24.2% -1,572 ↑ +24.4% +24.4%
2016.12 2016/02/12 当初予 29 - - - -2,117 - - - -2,102 - - - -2,080 - - -
2015.12 2016/02/12 実 37 ↑ +15.6% +105.6% -999 ↑ +2.6% +2.6% -990 ↑ +1.0% -11.2% -878 ↑ +1.0% +1.8%
2015.12 2015/11/06 Q3予 32 → 0.0% +77.8% -1,026 → 0.0% 0.0% -1,000 → 0.0% -12.4% -887 → 0.0% +0.8%
2015.12 2015/08/05 Q2予 32 → 0.0% +77.8% -1,026 → 0.0% 0.0% -1,000 → 0.0% -12.4% -887 → 0.0% +0.8%
2015.12 2015/05/08 修正予 32 ↑ +77.8% +77.8% -1,026 - - - -1,000 ↓ -12.4% -12.4% -887 ↑ +0.8% +0.8%
2015.12 2015/02/13 当初予 18 - - - - - - - -890 - - - -894 - - -
2014.12 2015/02/13 実 - - - - - - - - - - - - - - - -
2014.12 2014/11/14 修正予 25 ↓ -97.7% -97.7% -1,003 ↓ -7815.4% -7815.4% -1,015 ↓ -2516.7% -2516.7% -1,020 ↓ -2784.2% -2784.2%
2014.12 2014/08/01 Q2予 1,068 → 0.0% 0.0% 13 → 0.0% 0.0% 42 → 0.0% 0.0% 38 → 0.0% 0.0%
2014.12 2014/05/09 Q1予 1,068 → 0.0% 0.0% 13 → 0.0% 0.0% 42 → 0.0% 0.0% 38 → 0.0% 0.0%
2014.12 2014/02/14 当初予 1,068 - - - 13 - - - 42 - - - 38 - - -
2013.12 2014/02/14 実 68 - - - -604 - - - -616 - - - -621 - - -
シェア ツイート
ページトップへ戻る